[The effects of Sinecod intravenously upon respiration and circulation in patients with chronic obstructive pulmonary diseases (author's transl)].
D000996:Antitussive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D004048:Diethylamines / Q000627:therapeutic use; D004341:Drug Evaluation; D005019:Ethyl Ethers / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D010654:Phenylbutyrates / Q000008:administration & dosage / Q000627:therapeutic use*; D010993:Plethysmography, Whole Body; D013147:Spirometry
D000996:Antitussive Agents; D004048:Diethylamines; D005019:Ethyl Ethers; D010654:Phenylbutyrates; C006841:butamirate
Die Wirkung von Sinecod intravenös auf Atmung und Kreislauf bei Patienten mit chronisch-obstruktiver Atemwegserkrankung